Top Section/Ad
Top Section/Ad
Most recent
◆ Issuers opt for extra guidance as market softens ◆ Enexis takes size at six years ◆ DSM-Firmenich lands tight
This week's flurry of deals takes year to date volume beyond £8bn
Tech giant's meditation on permanence offered investors a juicy a pick-up for taking just a little more duration risk
Disney joins tech giant with first dollar deal in over five years
More articles/Ad
More articles/Ad
More articles
-
Barings is partnering up with Mubadala, the Abu Dhabi sovereign wealth fund, to provide $3.5bn of direct lending to mid-market companies in Europe.
-
Goldman Sachs has given new titles to leaders in its credit finance, investment grade capital markets and equity capital markets businesses. -
Chanel, the French luxury brand, is meeting investors over the next two days to market a sustainability-linked bond, the first from its sector and from an unrated company. The deal comes as the European Central Bank has changed a policy that had slowed the market's development.
-
Goldman Sachs has named new global M&A bosses, with the incumbents moving to become chairs of the business.
-
Fresenius, the German healthcare company, pushed ahead with a €1bn dual tranche no-grow trade on Monday, despite an issuer in another sector pulling its deal as wider markets plummeted.
-
German hospital operator Asklepios Kliniken launched a Schuldschein on Monday with an initial target of €200m. Investors have doubled down on their interest in pharmaceutical firms this year and throughout the pandemic, prompting a substantial increase in the market’s exposure to the sector.
